We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Enabled Wearable Patches Reveal Undetected Hormone Disruption in Infertility

By HospiMedica International staff writers
Posted on 22 May 2026

Unexplained infertility, diagnosed when routine evaluations identify no clear cause, affects 15–30% of couples and often leaves patients with limited options. More...

Standard testing typically captures hormone levels at single time points, even though reproductive hormones fluctuate throughout the day and across the menstrual cycle. As a result, clinically relevant disruptions in hormone timing may go undetected. To address this gap, researchers have developed AI-enabled wearable patches and rhythm analytics that continuously track endocrine patterns.

Investigators from Oxford University and New Anglia University created an AI-enabled wearable skin sensor patch and an analysis metric called Endocrine Rhythm Integrity (ERI). The patch captures reproductive hormone signals repeatedly over several days. ERI evaluates whether hormones change with correct timing and coordination rather than as isolated values.

In a study of 102 men aged 22–38 in Georgia and the United States with normal morning total testosterone (12–35 nmol/L), levels were recorded every 15 minutes for four days. Symptomatic participants showed significantly disrupted testosterone rhythms despite normal laboratory values, which correlated with reduced sperm concentration and symptoms of androgen deficiency. 

A second study of 312 women aged 18–22 with regular cycles found that lower ERI scores predicted unexplained infertility and were associated with higher implantation failure. Results were presented at the 28th European Congress of Endocrinology in Prague.

“Our AI-driven rhythm analyses were significantly better at identifying subclinical reproductive dysfunction than conventional testing, suggesting that both female and male endocrine disorders may not simply be disorders of hormone quantity, but rather disorders of hormonal timing, synchronization and biological rhythm,” said Dr. Tinatin Kutchukhidze of Oxford University and New Anglia University.

"We aim to move fertility care toward predictive, rhythm-based reproductive medicine, where clinicians can identify dysfunction earlier, personalize interventions and improve outcomes before infertility becomes clinically evident," said Dr. Kutchukhidze.

Related Links
European Society of Endocrinology
Oxford University
New Anglia University 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Glucose Meter
StatStrip®
New
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Even though the team’s new bioelectronic is only about the size of a fingertip, it could offer an effective and biocompatible approach to addressing high blood pressure (photo courtesy of Tao Zhou/Penn State)

Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study

Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.